Currently out of the existing stock ratings of Felipe Ucros, 4 are a BUY (80%), 1 are a HOLD (20%).

Felipe Ucros

Work Performance Price Targets & Ratings Chart

Analyst Felipe Ucros, currently employed at SCOTIABANK, carries an average stock price target met ratio of 100% that have a potential upside of 31.78% achieved within 475 days.

Felipe Ucros’s has documented 6 price targets and ratings displayed on 2 stocks. The coverage is on the Consumer Defensive sector.

Most recent stock forecast was given on KOF, Coca-Cola Femsa SAB de CV ADR at 28-Apr-2025.

Wall Street Analyst Felipe Ucros

Analyst best performing recommendations are on KOF (COCA-COLA FEMSA SAB DE CV ADR).
The best stock recommendation documented was for KOF (COCA-COLA FEMSA SAB DE CV ADR) at 7/27/2021. The price target of $61 was fulfilled within 475 days with a profit of $14.71 (31.78%) receiving and performance score of 0.67.

Average potential price target upside

CCU Compania Cervecerias Unidas SA ADR KOF Coca-Cola Femsa SAB de CV ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell

$10

$-1.53 (-13.27%)

1 months 4 days ago
(10-Sep-2025)

1/4 (25%)

$-2.11 (-17.42%)

9

Sell

$10

$-1.53 (-13.27%)

$21

1 years 2 months 7 days ago
(07-Aug-2024)

3/7 (42.86%)

$-0.58 (-5.48%)

69

Buy

$17

$5.47 (47.44%)

$19

3 years 5 months 19 days ago
(25-Apr-2022)

1/3 (33.33%)

$4.89 (40.38%)

587

Buy

$29

$17.47 (151.52%)

$21

8 years 6 months 3 days ago
(11-Apr-2017)

1/2 (50%)

$11.33 (64.12%)

905

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Felipe Ucros is most bullish on?

Potential upside of $0 has been obtained for KOF (COCA-COLA FEMSA SAB DE CV ADR)

What Year was the first public recommendation made by Felipe Ucros?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?